Natural history of HIV-1 infection and predictors of survival in a cohort of HIV-1 seropositive injecting drug users. (Q52273828)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583491%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Natural history of HIV-1 infection and predictors of survival in a cohort of HIV-1 seropositive injecting drug users (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583491%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

author name string

L S Brown

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583491%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

N S Siddiqui

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583491%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

A F Chu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583491%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583491%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Medical Association

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583491%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583491%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583491%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

37-42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583491%20AND%20SRC:MED&resulttype=core&format=json

Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex

15 October 2019

cites work

1 reference

12 December 2020

AIDS and self-organization among intravenous drug users

1 reference

12 December 2020

Preliminary analysis of the Concorde trial. Concorde Coordinating Committee

1 reference

12 December 2020

Progressive CD4 cell depletion and death in zidovudine-treated patients

1 reference

12 December 2020

The impact of clinical trial protocols on patient care systems in a large city hospital. Access for the socially disadvantaged

1 reference

12 December 2020

Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients

1 reference

12 December 2020

Decline in HIV-1 seroprevalence and low seroconversion rate among injecting drug users at a methadone maintenance program in New York City

1 reference

12 December 2020

Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group

1 reference

12 December 2020

Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn Community Programs for Clinical Research on AIDS

1 reference

12 December 2020

Considerations in choice of a clinical endpoint for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

1 reference

12 December 2020

CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine

1 reference

12 December 2020

Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection

1 reference

12 December 2020

Searching for markers on the AIDS trail

1 reference

12 December 2020

A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group

1 reference

12 December 2020

The first and second decades of AIDS among injecting drug users

1 reference

12 December 2020

A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study

1 reference

12 December 2020

Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users

1 reference

12 December 2020

Laboratory markers as potential surrogates for clinical outcomes in AIDS trials.

1 reference

12 December 2020

A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

1 reference

12 December 2020

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

1 reference

12 December 2020

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

12 December 2020

No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals. A report from the Multicenter AIDS Cohort Study

1 reference

12 December 2020

HIV infection among intravenous drug users: epidemiology and risk reduction.

1 reference

12 December 2020

Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users.

1 reference

12 December 2020

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

12 December 2020

No seroconversions among steady sex partners of methadone-maintained HIV-1-seropositive injecting drug users in New York City

1 reference

12 December 2020

Identifiers

1 reference